← Evidence map

ArticleFrontiers in oncology2025

Editorial: EGFR-TKIs for lung cancer treatment: development, application, and side effects.

Qinglin Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40475016